(Q36811750)

English

Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial

scientific article published on February 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

Europe PubMed Central

Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Sutton MS

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 February 1994

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Heart Journal

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

115-118

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

The stunned myocardium: prolonged, postischemic ventricular dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

29 September 2017

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

29 September 2017

Alpha-adrenergic mechanisms in myocardial ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

29 September 2017

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

29 September 2017

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

29 September 2017

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483628

27 June 2018

Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myocardial infarction: diagnostic and prognostic applications of two-dimensional echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8130017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.71.2.115

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36811750&oldid=1657357994"